RoosterBio Inc. logo — Accelerating hMSC & Exosome Product & Process Development to...

RoosterBio Inc.

Accelerating hMSC & Exosome Product & Process Development to Fuel Rapid Implementation of Scalable Advanced Therapies

Founded 2013 United States Frederick, United States 52 employees Venture round Total: $40.15M Biotechnology, Medical Devices

General Information

Company Name RoosterBio Inc.
Founded Year 2013
Location United States Frederick, United States
Founders / Decision Makers
Team member
Employees 52
Industries Biotechnology, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with RoosterBio Inc.. To contact RoosterBio Inc., visit roosterbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RoosterBio Inc. compare?

A PDF of RoosterBio Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RoosterBio Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RoosterBio Inc.

RoosterBio Inc. is a biotechnology startup founded in 2012 with a focus on accelerating human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development. Their mission is to fuel the rapid implementation of scalable advanced therapies. The company provides high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions, paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. This United States-based company has recently received a significant $6.91M Venture Round investment on 08 March 2024. RoosterBio's optimized, scalable processes, Type II Drug Master Files, and cGMP products have enabled therapeutic programs to traverse their path to clinical translation in under one year. The company is driven by their client's success and aims to create a world where safe and effective advanced therapies are rapidly developed and widely available on a global scale.

Business keywords: Regenerative Medicine, Stem Cells, Cell Manufacturing, Advanced Therapies, Process Development, hMSCs, Exosome, Sustainable Industry, Media Systems, Collaborative Relationships, Standardization, Cost Savings, Innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $12.00M -
08 Mar 2024
Debt Financing Undisclosed -
08 Mar 2024
Series B $6.50M 3
Dynamk Capital, Bioeconomy Capital +1
11 Sep 2019
Series B $15.00M 1
Dynamk Capital
06 Aug 2019
Grant $300.00K 1
Maryland Stem Cell Research Fund (MSCRF)
13 Jun 2019
Series A $6.00M -
15 Mar 2017
Seed Round $250.00K -
25 Feb 2014
Seed Round $100.00K -
14 Jan 2014

RoosterBio Inc. Alternatives & Competitors

View All Alternatives
RoosterBio Inc. vs

Advanced therapy medicinal products, medical devices and dermocosmetics for regenerative medicine.

Grant
41 employees
Biotechnology, Health Care
RoosterBio Inc. vs

Redefining the future of therapeutic transplants through advanced stem cell grafts.

Series B
Biotechnology, Medical Devices
RoosterBio Inc. vs

Pioneering regenerative therapies for life-threatening diseases with a robust clinical pipeline and...

Series B
Biotechnology, Health Care

FAQ About RoosterBio Inc.

Accelerating hMSC & Exosome Product & Process Development to Fuel Rapid Implementation of Scalable Advanced Therapies
RoosterBio Inc. was founded in 2013.
RoosterBio Inc. is headquartered in Frederick, United States.
RoosterBio Inc. operates in Biotechnology and Medical Devices. Its work centres on Regenerative Medicine, Stem Cells, Cell Manufacturing and Advanced Therapies.
RoosterBio Inc. has approximately 52 employees.
RoosterBio Inc. has completed 8 funding rounds, raising a total of $40.15M. The latest funding stage is Venture round.
Top alternatives and competitors to RoosterBio Inc. include Histocell. Regenerative Medicine, StemCo Biomedical, Juventas Therapeutics, DERMA INNOVATE, S.L.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RoosterBio Inc. and Histocell. Regenerative Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RoosterBio Inc., https://bouncewatch.com/company/roosterbio-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes